Thalamic deep brain stimulation for tremor-predominant Parkinson's disease

J. D. Putzke, R. E. Wharen, Zbigniew K Wszolek, M. F. Turk, A. J. Strongosky, R. J. Uitti

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Objectives. Determine the long-term efficacy of thalamic deep brain stimulation (DBS) for treatment of tremor among individuals with tremor-predominant Parkinson's disease (PD). Design. Longitudinal, unblinded assessment of tremor and activities of daily living (ADL) at baseline (pre-surgical), and post-operative intervals of 1, 3, and 12 months, and annually thereafter up to 3 years. Methods. A clinical series of 19 individuals undergoing placement of a DBS system for treatment of PD-related tremor. A battery of subjective and objective measures of tremor was completed at planned pre- and post-operative intervals. Results. Stimulation was associated with significant improvement on subjective and objective measures of ADL performance, midline tremor, and contralateral upper and lower extremity tremor, including parkinsonian resting and action tremors, over the follow-up period. Ipsilateral tremor showed little or no effect of stimulation after the first 3 months. Antiparkinsonian medication use and stimulation parameters showed little or no change over the course of follow-up. About half (53%) of all individuals reported at least one side effect, generally mild, during the follow-up period, with paresthesias and dysarthria being the most common. A total of two leads required replacement due to (1) infection, and (2) adverse side effects (i.e. burning and tingling with stimulation). Conclusion. DBS is associated with stable tremor control in PD. Side-effects are typically easily managed with stimulation adjustments, although in some cases lead replacement may be required.

Original languageEnglish (US)
Pages (from-to)81-88
Number of pages8
JournalParkinsonism and Related Disorders
Volume10
Issue number2
DOIs
StatePublished - Dec 2003

Fingerprint

Deep Brain Stimulation
Tremor
Parkinson Disease
Activities of Daily Living
Antiparkinson Agents
Dysarthria
Paresthesia
Lower Extremity

Keywords

  • Deep brain stimulation
  • Longitudinal
  • Parkinson's disease
  • Side-effects
  • Tremor
  • Ventral intermediate nucleus

ASJC Scopus subject areas

  • Aging
  • Clinical Neurology
  • Neurology

Cite this

Thalamic deep brain stimulation for tremor-predominant Parkinson's disease. / Putzke, J. D.; Wharen, R. E.; Wszolek, Zbigniew K; Turk, M. F.; Strongosky, A. J.; Uitti, R. J.

In: Parkinsonism and Related Disorders, Vol. 10, No. 2, 12.2003, p. 81-88.

Research output: Contribution to journalArticle

Putzke, J. D. ; Wharen, R. E. ; Wszolek, Zbigniew K ; Turk, M. F. ; Strongosky, A. J. ; Uitti, R. J. / Thalamic deep brain stimulation for tremor-predominant Parkinson's disease. In: Parkinsonism and Related Disorders. 2003 ; Vol. 10, No. 2. pp. 81-88.
@article{63d1aad0bea9482a9a4ebfd468ad0551,
title = "Thalamic deep brain stimulation for tremor-predominant Parkinson's disease",
abstract = "Objectives. Determine the long-term efficacy of thalamic deep brain stimulation (DBS) for treatment of tremor among individuals with tremor-predominant Parkinson's disease (PD). Design. Longitudinal, unblinded assessment of tremor and activities of daily living (ADL) at baseline (pre-surgical), and post-operative intervals of 1, 3, and 12 months, and annually thereafter up to 3 years. Methods. A clinical series of 19 individuals undergoing placement of a DBS system for treatment of PD-related tremor. A battery of subjective and objective measures of tremor was completed at planned pre- and post-operative intervals. Results. Stimulation was associated with significant improvement on subjective and objective measures of ADL performance, midline tremor, and contralateral upper and lower extremity tremor, including parkinsonian resting and action tremors, over the follow-up period. Ipsilateral tremor showed little or no effect of stimulation after the first 3 months. Antiparkinsonian medication use and stimulation parameters showed little or no change over the course of follow-up. About half (53{\%}) of all individuals reported at least one side effect, generally mild, during the follow-up period, with paresthesias and dysarthria being the most common. A total of two leads required replacement due to (1) infection, and (2) adverse side effects (i.e. burning and tingling with stimulation). Conclusion. DBS is associated with stable tremor control in PD. Side-effects are typically easily managed with stimulation adjustments, although in some cases lead replacement may be required.",
keywords = "Deep brain stimulation, Longitudinal, Parkinson's disease, Side-effects, Tremor, Ventral intermediate nucleus",
author = "Putzke, {J. D.} and Wharen, {R. E.} and Wszolek, {Zbigniew K} and Turk, {M. F.} and Strongosky, {A. J.} and Uitti, {R. J.}",
year = "2003",
month = "12",
doi = "10.1016/j.parkreldis.2003.09.002",
language = "English (US)",
volume = "10",
pages = "81--88",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Thalamic deep brain stimulation for tremor-predominant Parkinson's disease

AU - Putzke, J. D.

AU - Wharen, R. E.

AU - Wszolek, Zbigniew K

AU - Turk, M. F.

AU - Strongosky, A. J.

AU - Uitti, R. J.

PY - 2003/12

Y1 - 2003/12

N2 - Objectives. Determine the long-term efficacy of thalamic deep brain stimulation (DBS) for treatment of tremor among individuals with tremor-predominant Parkinson's disease (PD). Design. Longitudinal, unblinded assessment of tremor and activities of daily living (ADL) at baseline (pre-surgical), and post-operative intervals of 1, 3, and 12 months, and annually thereafter up to 3 years. Methods. A clinical series of 19 individuals undergoing placement of a DBS system for treatment of PD-related tremor. A battery of subjective and objective measures of tremor was completed at planned pre- and post-operative intervals. Results. Stimulation was associated with significant improvement on subjective and objective measures of ADL performance, midline tremor, and contralateral upper and lower extremity tremor, including parkinsonian resting and action tremors, over the follow-up period. Ipsilateral tremor showed little or no effect of stimulation after the first 3 months. Antiparkinsonian medication use and stimulation parameters showed little or no change over the course of follow-up. About half (53%) of all individuals reported at least one side effect, generally mild, during the follow-up period, with paresthesias and dysarthria being the most common. A total of two leads required replacement due to (1) infection, and (2) adverse side effects (i.e. burning and tingling with stimulation). Conclusion. DBS is associated with stable tremor control in PD. Side-effects are typically easily managed with stimulation adjustments, although in some cases lead replacement may be required.

AB - Objectives. Determine the long-term efficacy of thalamic deep brain stimulation (DBS) for treatment of tremor among individuals with tremor-predominant Parkinson's disease (PD). Design. Longitudinal, unblinded assessment of tremor and activities of daily living (ADL) at baseline (pre-surgical), and post-operative intervals of 1, 3, and 12 months, and annually thereafter up to 3 years. Methods. A clinical series of 19 individuals undergoing placement of a DBS system for treatment of PD-related tremor. A battery of subjective and objective measures of tremor was completed at planned pre- and post-operative intervals. Results. Stimulation was associated with significant improvement on subjective and objective measures of ADL performance, midline tremor, and contralateral upper and lower extremity tremor, including parkinsonian resting and action tremors, over the follow-up period. Ipsilateral tremor showed little or no effect of stimulation after the first 3 months. Antiparkinsonian medication use and stimulation parameters showed little or no change over the course of follow-up. About half (53%) of all individuals reported at least one side effect, generally mild, during the follow-up period, with paresthesias and dysarthria being the most common. A total of two leads required replacement due to (1) infection, and (2) adverse side effects (i.e. burning and tingling with stimulation). Conclusion. DBS is associated with stable tremor control in PD. Side-effects are typically easily managed with stimulation adjustments, although in some cases lead replacement may be required.

KW - Deep brain stimulation

KW - Longitudinal

KW - Parkinson's disease

KW - Side-effects

KW - Tremor

KW - Ventral intermediate nucleus

UR - http://www.scopus.com/inward/record.url?scp=0345687954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345687954&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2003.09.002

DO - 10.1016/j.parkreldis.2003.09.002

M3 - Article

C2 - 14643997

AN - SCOPUS:0345687954

VL - 10

SP - 81

EP - 88

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - 2

ER -